Relationship between cardio-ankle vascular index and N-terminal pro-brain natriuretic peptide in hypertension and coronary heart disease subjects

被引:6
|
作者
Wang, Hongyu [1 ]
Liu, Jinbo [1 ]
Zhao, Hongwei [1 ]
Zhou, Yingyan [1 ]
Zhao, Xujing [1 ]
Song, Yuejie [1 ]
Li, Lihong [1 ]
Shi, Hongyan [1 ]
机构
[1] Peking Univ, Shougang Hosp, Dept Vasc Med, Beijing 100144, Peoples R China
关键词
Arterial stiffness; Biomarkers; PULSE-WAVE VELOCITY; ARTERIAL STIFFNESS; CARDIOVASCULAR EVENTS; COMMUNITY; FAILURE; CAVI; ATHEROSCLEROSIS; POPULATION; BIOMARKERS; MORTALITY;
D O I
10.1016/j.jash.2014.05.009
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Arterial stiffness is an independent predictor for vascular diseases. Cardio-ankle vascular index (CAVI) is a new index of arterial stiffness. N-terminal pro-brain natriuretic peptide (NT-proBNP) is a strong prognostic marker in advanced stage of coronary heart disease (CHD). In the present study, we investigated the relationship between CAVI and NT-proBNP in hypertension and CHD subjects. Five hundred one subjects (male/female, 209/292) from Vascular Medicine of Peking University Shougang Hospital were divided into four groups: healthy group (n = 186), hypertension group (n = 159), CHD group (n = 45), and hypertension with CHD group (n = 111). CAVI was measured using VS-1000 apparatus. Our results showed that CAVI was significantly higher in hypertension subjects with CHD than in healthy and hypertension group, respectively (8.42 +/- 1.51 vs. 7.77 +/- 1.19; 8.42 +/- 1.51 vs. 7.92 +/- 1.11; both P <.05). NT-proBNP was significantly higher in hypertension subjects with CHD than in healthy, hypertension, and CHD group, respectively (422.48 +/- 761.60 vs. 174.29 +/- 415.48; 422.48 +/- 761.60 vs. 196.14 +/- 299.16; 422.48 +/- 761.60 vs. 209.66 +/- 242.66; all P <.05). And after log transformation of NT-proBNP, this phenomenon also exists (2.32 +/- 0.47 vs. 2.03 +/- 0.40; 2.32 +/- 0.47 vs. 2.09 +/- 0.44; 2.32 +/- 0.47 vs. 2.12 +/- 0.42; all P <.05). There was positive correlation between log NT-proBNP and CAVI in the entire study group, healthy group, and nonhealthy group (r = 0.235, P <.001; r = 0.184, P =.023; r = 0.237, P <.001; respectively). Multivariate analysis showed that NT-proBNP was an independent associating factor of CAVI in all subjects (beta=0.150, P =.021). Our present study showed that CAVI and NT-proBNP were significantly higher in hypertension subjects with CHD compared with healthy and hypertension groups. There was significant correlation between NT-proBNP and CAVI, which indicates the relationship between arterial stiffness and biomarkers in vascular-related diseases. Crown Copyright (C) 2014 Published by Elsevier Inc. on behalf of American Society of Hypertension. All rights reserved.
引用
收藏
页码:637 / 643
页数:7
相关论文
共 50 条
  • [11] N-terminal pro-brain natriuretic peptide in systemic lupus erythematosus: Relationship with inflammation, augmentation index, and coronary calcification
    Chung, Cecilia P.
    Solus, Joseph F.
    Oeser, Annette
    Avalos, Ingrid
    Kurnik, Daniel
    Raggi, Paolo
    Stein, C. Michael
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (07) : 1314 - 1319
  • [12] Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension
    Okura, Takafumi
    Watanabe, Sanae
    Kurata, Mie
    Manabe, Seiko
    Koresawa, Mitsuko
    Irita, Jun
    Enomoto, Daijiro
    Miyoshi, Ken-ichi
    Fukuoka, Tomikazu
    Higaki, Jitsuo
    HYPERTENSION RESEARCH, 2007, 30 (04) : 335 - 340
  • [13] The Relationship Between N-Terminal Pro-Brain Natriuretic Peptide Levels and Poor Outcomes in Covid-19 Patients
    Soney, Hywel
    Sidhu, Manavjot S.
    CIRCULATION, 2023, 148
  • [14] Efficacy of N-terminal pro-brain natriuretic peptide digit number for screening of cardiac disease in new haemodialysis patients
    Iwasaki, Masaki
    Joki, Nobuhiko
    Tanaka, Yuri
    Ikeda, Nobutaka
    Hayashi, Toshihide
    Kubo, Shun
    Asakawa, Takasuke
    Takahashi, Yasunori
    Hirahata, Koichi
    Imamura, Yoshihiko
    Hase, Hiroki
    NEPHROLOGY, 2013, 18 (07) : 497 - 504
  • [15] N-terminal pro-brain natriuretic peptide in acute Kawasaki disease correlates with coronary artery involvement
    Adjagba, Philippe M.
    Desjardins, Laurent
    Fournier, Anne
    Spigelblatt, Linda
    Montigny, Martine
    Dahdah, Nagib
    CARDIOLOGY IN THE YOUNG, 2015, 25 (07) : 1311 - 1318
  • [16] Relationship between left ventricular preload and N-terminal pro-brain natriuretic peptide in obese patients
    Tsutamoto, Takayoshi
    Sakai, Hiroshi
    Yamamoto, Takashi
    Nakagawa, Yoshihisa
    JOURNAL OF CARDIOLOGY, 2020, 76 (06) : 580 - 584
  • [17] Association between N-terminal pro-brain natriuretic peptide and quality of life in adult patients with congenital heart disease
    Younge, John O.
    Eindhoven, Jannet A.
    Utens, Elisabeth W. M. J.
    Opic, Petra
    Cuypers, Judith A. A. E.
    van den Bosch, Annemien E.
    Witsenburg, Maarten
    van Domburg, Ron T.
    Hunink, M. G. Myriam
    Roos-Hesselink, Jolien W.
    CARDIOLOGY IN THE YOUNG, 2015, 25 (02) : 288 - 294
  • [18] Paradox of the Relationship between Cardio-Ankle Vascular Index and Ankle-Brachial Index in Patients with Lower Extremity Artery Disease
    Sotoda, Yoko
    Hirooka, Shigeki
    Orita, Hiroyuki
    Wakabayashi, Ichiro
    ANNALS OF VASCULAR DISEASES, 2023, 16 (04) : 253 - 260
  • [19] Determination and stability of N-terminal pro-brain natriuretic peptide in saliva samples for monitoring heart failure
    Bellagambi, Francesca G.
    Petersen, Christina
    Salvo, Pietro
    Ghimenti, Silvia
    Franzini, Maria
    Biagini, Denise
    Hangouet, Marie
    Trivella, Maria Giovanna
    Di Francesco, Fabio
    Paolicchi, Aldo
    Errachid, Abdelhamid
    Fuoco, Roger
    Lomonaco, Tommaso
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [20] The biomarker N-terminal pro-brain natriuretic peptide and liver diseases
    Wang, Ling
    Geng, Jiabao
    Li, Jie
    Li, Tong
    Matsumori, Akira
    Chang, Yibin
    Lu, Fengmin
    Zhuang, Hui
    CLINICAL AND INVESTIGATIVE MEDICINE, 2011, 34 (01): : E30 - E37